Electronic Cigarette Related Lung Damage

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Electronic Cigarette Related Lung Damage trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2/3

NCT06856525

Dissolved Phase HXe-129 MRI: A Novel Biomarker to Quantify Pulmonary Pathology

A two-center, longitudinal assessment of 40 electronic cigarette users and 40 healthy controls at the initial visit and a follow-up visit 12 months later. This…

United States80 participantsStarted 2024-12-19

Treatment: Hyperpolarized xenon 129, Cardiopulmonary Stress Test

Electronic Cigarette Related Lung Damage

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Dissolved Phase HXe-129 MRI: A Novel Biomarker to Quantify Pulmonary Pathology

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Dissolved Phase HXe-129 MRI: A Novel Biomarker to Quantify Pulmonary Pathology

All recent trials (1 shown)